NWAM LLC’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
Other funds holding NVO
DAM
F
NWAM LLC's NVO Position: Q1 2026 in Review
NWAM LLC increased its Novo Nordisk (NVO) stake by 331% in Q1 2026, buying an estimated $752K and bringing the position to 20,662 shares worth $759K. The position accounts for 0.04% of the portfolio, ranked #329.
NWAM LLC first reported a position in NVO in Q1 2023 and has held it in 8 quarters since. 1,271 funds tracked by Wall St. Rank hold NVO as of Q1 2026.
- NWAM LLC held 20,662 shares of Novo Nordisk worth $759K as of Q1 2026.
- NWAM LLC bought 15,872 Novo Nordisk shares in Q1 2026, an estimated $752K.
- Novo Nordisk made up 0.04% of NWAM LLC's portfolio in Q1 2026, its #329 holding.
- NWAM LLC first reported a position in Novo Nordisk in Q1 2023 and has held it in 8 quarters since.
- 1,271 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.
Based on NWAM LLC's 13F filing for Q1 2026, filed 4 May 2026.